ClinicalTrials.gg
RecruitingNCT05585099Updated Jun 22, 2023

Effects of Lower Body Positive Pressure in People With Knee Osteoarthritis

An interventional study of Exercise in Knee Osteoarthritis, sponsored by Qassim University. Recruiting at 2 sites in Saudi Arabia. Open to participants aged 40 Years to 75 Years. Per ClinicalTrials.gov, last updated 2023-06-22.

Sponsored by Qassim University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Nov 2024, 2 years ago, but the record still lists the study as recruiting.
  • Started Jun 2023; still recruiting 3 years 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
26
Allocation
Randomized
Ages
40 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 27 studies in Osteoarthritis, Knee with a site in Saudi Arabia — 5 open to participants now, 5 under way, none of them phase 3. Osteoarthritis, Knee · Saudi Arabia.

Planned enrollment
22nd of 24
26 · median 44
Started
2023
with 2 others
No phase
23 of 27
5 open now
Registered
10th of 27
by date

Among the 27 studies in Osteoarthritis, Knee with a site in Saudi Arabia, this one is the 22nd largest by planned enrollment of the 24 interventional ones that give a count, is one of 3 that started in 2023, is one of 23 with no phase, and was the 10th registered.

Osteoarthritis, Knee

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

Browse Osteoarthritis, Knee studies →

Open to participants now

5 of the 27 studies in Osteoarthritis, Knee with a site in Saudi Arabia are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in Saudi Arabia have not opened yet or have stopped. Only those recruiting at a site in Saudi Arabia →

Who these studies take

Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.

This study: 40 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 27 studies in Osteoarthritis, Knee with a site in Saudi Arabia, or all of them as a file.
02

Study summary

The goal of this clinical trial is to compare effects of retro walking exercise versus forward walking using lower body positive pressure on knee pain, physical function, and quadriceps muscle strength in people with mild to moderate knee OA. The secondary aim is to compare effects of retro walking exercise versus forward walking using lower body positive pressure on mobility function, balance, and self-reported health outcomes in people with mild to moderate knee OA. The main questions it aims to answer are:

  • Does retro walking exercise improve knee pain, physical function and Quadriceps muscle strength compared to forward walking exercise using lower body positive pressure in people with mild to moderate knee osteoarthritis?
  • Does retro walking exercise improve Mobility function, balance, and self-reported health outcomes compared to forward walking exercise using lower body positive pressure in people with mild to moderate knee osteoarthritis?

Participants will walk (retro versus forward) on a lower body positive pressure treadmill.

If there is a comparison group: Researchers will compare [retro walking compares to forward walking] to see if [improve in knee pain, physical function, and quadriceps muscles strength]

03

Conditions studied

  • Knee Osteoarthritis
04

Who can participate

Ages eligible
40 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Mild to moderate knee osteoarthritis
  • Edge bigger or equal 40 years
  • Knee pain reported by participants in the past 30 days
  • One or both knees osteoarthritis graded with Kellgren \& Lawrence grade 1 - 3

Exclusion criteria

Exclusion Criteria:

  • If they didn't meet the inclusion criteria
  • History of hip, knee or ankle injury or surgery within the last year
  • Kellgren \& Lawrence grade > 3 of severe knee OA
  • Diagnosed with rheumatoid arthritis
  • History of knee injection with any medicine that reduce pain within the last year
  • History of other medical condition that would disturb normal walking function
  • Receive physical therapy in the last three months
  • Pregnant
  • Other conditions that are Contra indication to lower body positive pressure.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
26 participants (estimated)

Study arms

  • Experimental
    Experimental

    Participants will walk in retro walking exercise on lower body positive pressure treadmill.

    Other: Exercise

  • Other
    Control

    Participants will walk in forward walking exercise on lower body positive pressure treadmill.

    Other: Exercise

Interventions

  • OtherExercise

    Participants will stand on lower body positive pressure treadmill and participate in walking exercise.

    Also known as: Walking exercise

06

What researchers measure

Primary outcomes

  1. Numeric pain rating scale

    The NPRS is an 11-point scale with "0" representing "no pain" and "10" representing "most imaginable pain" used to assess pain intensity.

    Time frame: Change from baseline pain at 6 weeks

  2. Knee injury and osteoarthritis outcome score (KOOS)

    The KOOS is a self-reported, knee-specific questionnaire that is aimed to measure knee pain, symptoms, and level of disability during the last week.

    Time frame: Change from baseline pain, symptoms, and level of disability at 6 weeks.

  3. Thigh muscle strength test

    A Biodex isokinetic dynamometer (Model 4Pro) connected to a computer will be used to assess bilateral knee's flexor and extensor isometric muscle strength.

    Time frame: Change from baseline thigh muscle strength at 6 weeks.

Secondary outcomes

  1. Five times sit to stand test

    The FTSST is used to assess lower extremity strength and balance and is an indicator of postural control.

    Time frame: Change from baseline balance at 6 weeks.

  2. 3-M Backward Walk Test

    Patients will be instructed to walk backwards when the assessor says "go" and stop when the participant pass the end line colored tape. The participant will be allowed to look back.

    Time frame: Change from baseline backward walking at six weeks.

  3. Timed up and go test

    The TUG assesses functional mobility by assessing an individual's ability to stand up, walk 3 meters at a comfortable pace, turn 180 degrees, walk back 3 meters, and sit down

    Time frame: Change from baseline Functional mobility at six weeks.

  4. 4 square step test

    The test is designed to assess dynamic balance and coordination.

    Time frame: Change from baseline dynamic balance and coordination at six weeks

  5. Functional reach test

    FRT used to assess participant's stability and balance by measuring the maximum distance participant can reach forward while standing in fixed position.

    Time frame: Change from baseline static balance at six weeks

  6. 10-Meter Walk Test

    The 10-MWT evaluates walking speed over a short duration with or without an assistive device.

    Time frame: Change from baseline walking speed at six weeks

  7. 6 minute walk test

    6MWT assesses the distance walked over 6 minutes as a test of aerobic capacity and endurance.

    Time frame: Change from baseline aerobic capacity and endurance at six week

  8. Medical Outcomes Study Short Form 12 (SF-12)

    It is a health survey that evaluates health related quality of life in a clinical practice and research purpose

    Time frame: Change from baseline quality of life at six weeks

  9. Patient Health Questionnaire -9

    PHQ-9 is an instrument to evaluate depression symptoms among different populations.

    Time frame: Change from baseline depression at six week

  10. Rapid Assessment of Physical Activity

    RAPA is a 9-items, self-reported questionnaire measures the levels of physical activity of adult older than 50 years.

    Time frame: Change from baseline physical activity at six week

07

Study locations

2 of 2 sites recruiting
  • Qassim university medical city
    Buraydah, Almuledia 52373, Saudi Arabia
    Recruiting
  • Medical City in Qassim University
    Buraidah, Saudi Arabia
    Recruiting
    • Sattam Almutairi · Contact0505102644
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2023 (actual). Primary completion is estimated for Nov 2024, 16 months after the start.

Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 16 months is below that.

Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 15, 2022
First posted
Oct 18, 2022
StartActual
Jun 15, 2023
Primary completionEst.
Nov 1, 2024
CompletionEst.
Nov 1, 2024
Last update
Jun 22, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 22, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05585099
Lead sponsor
Qassim University
Responsible party
Sattam Almutairi (Assistant professor, Qassim University) — Principal investigator
First posted
Oct 18, 2022
Start date
Jun 15, 2023
Primary completion
Nov 1, 2024 (estimated)
Completion
Nov 1, 2024 (estimated)
Last update
Jun 22, 2023

Study contacts

Sattam M Almutairi, Ph.D
Contact
A.sattam@qu.edu.sa
+966505102644

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion